FDA Encourages Breakthrough Applications for Neglected Tropical Diseases

Drug Industry Daily
The FDA is reaching out to sponsors of trials of therapies for neglected tropical diseases with new final guidance that encourages them to seek accelerated approval pathways, such as breakthrough therapy designation and qualified infectious disease product status.

To View This Article:


Subscribe To Drug Industry Daily